English (US)
Translating Cutting-Edge Science into Health and Longevity Solutions
Cutting-edge technologies for health optimization and aging intervention from leading research institutions worldwide are integrated into data-driven, personalized health and longevity solutions.
Learn More ›
Cutting-Edge Multi-Omics Platform for Biological Pathway Analysis
By integrating multi-omics technologies with biological pathway analysis, the platform enables multidimensional profiling of human health and aging.
Learn More ›
AI-Powered Biomedical Applications Platform
Large-scale AI models, advanced algorithms, and bioinformatics enable more efficient drug discovery and development, as well as smarter healthcare solutions.
Learn More ›
Gene Therapy Pipeline
Early-stage R&D programs explore cutting-edge fields such as gene editing, cellular reprogramming, and immunotherapy, with a focus on project development and validation of proposed technical approaches.
Learn More ›
AI-Powered Biomedical Applications Platform
Leveraging advanced large AI models, algorithms, and bioinformatics to substantially enhance R&D efficiency—and drawing on the scientific thinking and deep expertise of world-leading scientists—we are building a professional-grade health intelligence expert. The ESTOREL AI-Powered Biomedical Applications Platform bridges two domains. One is health services, represented by an application-side professional health intelligence expert system whose depth of expertise in delivering consumer health consultations in aging far exceeds that of conventional AI chatbots and online medical consultations. The other is cutting-edge biomedical technology R&D, where the platform accelerates AI-driven drug discovery from target prediction through to candidate molecule generation—substantially improving both R&D efficiency and R&D success rates.
Next-Generation Approaches to Aging and Disease Intervention
Early-stage R&D programs explore cutting-edge approaches to aging and disease intervention, including gene therapy and cellular reprogramming.
New ESTOREL
ESTOREL is a global biotechnology company focused on aging and longevity research. Building on our R&D capabilities in this field, we are committed to translating cutting-edge longevity science into practical health intervention pathways that everyone can understand, put into practice, and track over time.
Gene Therapy Pipeline
EST-625 and EST-626 are strategic R&D programs within our innovative therapeutics portfolio.
Learn More ›
Next-Generation Oral Candidate Program
EST-818 marks a new step forward in our development of systemic oral approaches to health optimization and aging intervention.
Learn More ›Our Global Vision
Our Mission
Making healthy longevity accessible to everyone.
Our Purpose
Grounded in scientific evidence, we translate cutting-edge longevity research into measurable, trackable approaches to aging and disease intervention.
Our Belief
Committed to advancing biomedical innovation to improve quality of life and extend healthspan for all.
Hallmarks of Aging ›
Building on the 14 hallmarks of aging described in Cell, we explore the key mechanisms underlying aging and potential intervention strategies.
Evidence and Translation ›
From Discovery to Evidence. From Evidence to Translation.
Technology Landscape ›
A continuously evolving map of technologies from leading research institutions worldwide, spanning senescent cell clearance, mTOR pathway homeostasis, mitophagy activation, and multi-pathway combination strategies.
Health and Longevity Solutions for Every Life Stage
ESTOREL brings together next-generation approaches to aging and disease intervention, systemic oral solutions, and personalized intervention plans to create an integrated, closed-loop approach to health and longevity.
Our Oral Solutions
Moving beyond traditional single-ingredient supplementation, we develop oral solutions designed to address multiple biological targets and pathways.
Personalized Health Intervention Plans
By connecting oral interventions, testing and retesting, and personalized care plans, we build a continuous, closed-loop approach to health management, which makes progress measurable, insights understandable, interventions actionable, and outcomes trackable over time.
Next-Generation Approaches to Aging and Disease Intervention
Advancing early-stage R&D programs and translational research in emerging fields such as gene editing, cell therapy, immunotherapy, and targeted therapeutics.